Featured

Captiva Verde (PWR.C): If Canadian shrooms aren’t legal, do business in Mexico

January 21, 2020 by Chris Parry

As we wait for the Canadian courts to repeat the process that made cannabis legal after decades in purgatory, some companies aren’t waiting around for their chance to claim a piece of the upcoming shroomaceuticals market.

Yield Growth Corp (BOSS.C) subsidiary takes on 18% of shroom clinical trial outfit

January 21, 2020 by Chris Parry

CBD product developer/retailer Yield Growth Corp (BOSS.C) has announced it has agreed to acquire 18% of Translational Life Sciences, a company that “aims to develop proprietary formulations using restricted substances to focus on unmet medical needs in opioid dependence, psychotic illness, pain management and traumatic brain injury, including concussion.”

Absolem: Laying the groundwork for the big mushroom shift to come

December 8, 2019 by Chris Parry

50 years I’ve been bumbling around this planet, and the best damn weekend I’ve had on it to date occurred recently, under the influence of mushrooms.


Latest

Roadman Investments (LITT.V) Amsterdam JV brings home Psychedelic Insights

February 6, 2020 by Joseph Mortonpsychedelic

Roadman Investments (LITT.V) is forming a California-based joint-venture with lifestyle centre Psychedelic Insights to open the first psilocybin therapy centre in the United States when the states get around to legalizing it.

The City of Santa Cruz joins the shroom-boom

January 30, 2020 by Joseph Mortonshroom-boom

The shroom-boom continues to develop as the City of Santa Cruz is the latest to decriminalize magic mushrooms.

Graph Blockchain’s (GBLC.C) latest shroom-venture shows they’re not willing to raise the white flag yet

January 24, 2020 by Joseph Morton

Graph Blockchain’s (GBLC.C) story is either going to be one of ultimate failure—an object lesson of what not to do for new companies—or an absolutely great comeback story, but what’s obvious is that they’re not willing to fly the white flag anytime soon.

Yield Growth (BOSS.C) subsidiary Flourish Mushrooms forms JV to do research and development in paradise

January 7, 2020 by Joseph MortonFlourish

Flourish Mushroom Labs, a subsidiary of Yield Growth (BOSS.C), entered into a binding letter of intent with Acres Agricultural Canada to form a JV in Saint Vincent and the Grenadines for the cultivation of psilocybin mushrooms, and for research and development into compounds and therapeutic uses for psychedelic mushrooms.